Copyright Reports & Markets. All rights reserved.

Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Artificial Saliva
      • 1.4.3 Salivary Stimulants
      • 1.4.4 Saliva Substitutes
      • 1.4.5 Drugs
      • 1.4.6 Salivary Pens
      • 1.4.7 Others
    • 1.5 Market by Application
      • 1.5.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Application (2019-2025)
      • 1.5.2 Retail Pharmacies
      • 1.5.3 Hospital Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Xerostomia (Dry Mouth Disease) Therapeutics Market Size
    • 2.2 Xerostomia (Dry Mouth Disease) Therapeutics Growth Trends by Regions
      • 2.2.1 Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Regions (2019-2025)
      • 2.2.2 Xerostomia (Dry Mouth Disease) Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Xerostomia (Dry Mouth Disease) Therapeutics Market Size by by Players
      • 3.1.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue by by Players (2014-2019)
      • 3.1.2 Global Xerostomia (Dry Mouth Disease) Therapeutics Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Xerostomia (Dry Mouth Disease) Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Xerostomia (Dry Mouth Disease) Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Xerostomia (Dry Mouth Disease) Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2014-2019)
    • 5.2 Xerostomia (Dry Mouth Disease) Therapeutics Key Players in North America
    • 5.3 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
    • 5.4 North America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2014-2019)
    • 6.2 Xerostomia (Dry Mouth Disease) Therapeutics Key Players in Europe
    • 6.3 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
    • 6.4 Europe Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application

    7 China

    • 7.1 China Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2014-2019)
    • 7.2 Xerostomia (Dry Mouth Disease) Therapeutics Key Players in China
    • 7.3 China Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
    • 7.4 China Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2014-2019)
    • 8.2 Xerostomia (Dry Mouth Disease) Therapeutics Key Players in Japan
    • 8.3 Japan Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
    • 8.4 Japan Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2014-2019)
    • 9.2 Xerostomia (Dry Mouth Disease) Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
    • 9.4 Southeast Asia Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application

    10 India

    • 10.1 India Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2014-2019)
    • 10.2 Xerostomia (Dry Mouth Disease) Therapeutics Key Players in India
    • 10.3 India Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
    • 10.4 India Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Xerostomia (Dry Mouth Disease) Therapeutics Market Size (2014-2019)
    • 11.2 Xerostomia (Dry Mouth Disease) Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Type
    • 11.4 Central & South America Xerostomia (Dry Mouth Disease) Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Acacia Pharma
      • 12.1.1 Acacia Pharma Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Xerostomia (Dry Mouth Disease) Therapeutics Introduction
      • 12.1.4 Acacia Pharma Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2014-2019))
      • 12.1.5 Acacia Pharma Recent Development
    • 12.2 Church & Dwight
      • 12.2.1 Church & Dwight Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Xerostomia (Dry Mouth Disease) Therapeutics Introduction
      • 12.2.4 Church & Dwight Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2014-2019)
      • 12.2.5 Church & Dwight Recent Development
    • 12.3 GlaxoSmithKline
      • 12.3.1 GlaxoSmithKline Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Xerostomia (Dry Mouth Disease) Therapeutics Introduction
      • 12.3.4 GlaxoSmithKline Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2014-2019)
      • 12.3.5 GlaxoSmithKline Recent Development
    • 12.4 Hikma Pharmaceuticals
      • 12.4.1 Hikma Pharmaceuticals Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Xerostomia (Dry Mouth Disease) Therapeutics Introduction
      • 12.4.4 Hikma Pharmaceuticals Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2014-2019)
      • 12.4.5 Hikma Pharmaceuticals Recent Development
    • 12.5 Lupin
      • 12.5.1 Lupin Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Xerostomia (Dry Mouth Disease) Therapeutics Introduction
      • 12.5.4 Lupin Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2014-2019)
      • 12.5.5 Lupin Recent Development
    • 12.6 OraCoat
      • 12.6.1 OraCoat Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Xerostomia (Dry Mouth Disease) Therapeutics Introduction
      • 12.6.4 OraCoat Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2014-2019)
      • 12.6.5 OraCoat Recent Development
    • 12.7 Parnell Pharmaceuticals
      • 12.7.1 Parnell Pharmaceuticals Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Xerostomia (Dry Mouth Disease) Therapeutics Introduction
      • 12.7.4 Parnell Pharmaceuticals Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2014-2019)
      • 12.7.5 Parnell Pharmaceuticals Recent Development
    • 12.8 Pendopharm
      • 12.8.1 Pendopharm Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Xerostomia (Dry Mouth Disease) Therapeutics Introduction
      • 12.8.4 Pendopharm Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2014-2019)
      • 12.8.5 Pendopharm Recent Development
    • 12.9 Pfizer
      • 12.9.1 Pfizer Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Xerostomia (Dry Mouth Disease) Therapeutics Introduction
      • 12.9.4 Pfizer Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2014-2019)
      • 12.9.5 Pfizer Recent Development
    • 12.10 Sun Pharmaceutical Industries
      • 12.10.1 Sun Pharmaceutical Industries Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Xerostomia (Dry Mouth Disease) Therapeutics Introduction
      • 12.10.4 Sun Pharmaceutical Industries Revenue in Xerostomia (Dry Mouth Disease) Therapeutics Business (2014-2019)
      • 12.10.5 Sun Pharmaceutical Industries Recent Development
    • 12.11 Synedgen

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      This report focuses on the global Xerostomia (Dry Mouth Disease) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Xerostomia (Dry Mouth Disease) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Acacia Pharma
      Church & Dwight
      GlaxoSmithKline
      Hikma Pharmaceuticals
      Lupin
      OraCoat
      Parnell Pharmaceuticals
      Pendopharm
      Pfizer
      Sun Pharmaceutical Industries
      Synedgen

      Market segment by Type, the product can be split into
      Artificial Saliva
      Salivary Stimulants
      Saliva Substitutes
      Drugs
      Salivary Pens
      Others

      Market segment by Application, split into
      Retail Pharmacies
      Hospital Pharmacies
      Online Pharmacies

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Xerostomia (Dry Mouth Disease) Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Xerostomia (Dry Mouth Disease) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Xerostomia (Dry Mouth Disease) Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now